Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.
Starr TN, Greaney AJ, Dingens AS, Bloom JD. · 2021
Read Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. by Starr TN, Greaney AJ, Dingens AS, Bloom JD. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8020059.txt.
Description
Starr and co-authors map every spike mutation that lets SARS-CoV-2 escape a leading antibody drug. The antibody LY-CoV555, also called bamlanivimab, targets the spike receptor-binding domain. It was used alone and in a cocktail with LY-CoV016. Viral evolution could, in time, defeat both. The team tested all single amino acid changes in the domain.
The authors report a complete escape map for each antibody and for the pair. E484K escapes LY-CoV555, while K417N/T escapes LY-CoV016. Both changes already circulate in the South African and Brazilian lineages. The L452R change in a Californian lineage also escapes LY-CoV555. A few single changes even beat the combined cocktail. The authors urge antibody designs that spread across more epitopes.
Catalog record
| CREATOR | Starr TN, Greaney AJ, Dingens AS, Bloom JD. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |